MedTrace Logo

A Prospective Observational Study on the Role of Transthoracic Ultrasound in Differentiating Tuberculous From Malignant Pleural Effusion

NCT05935696 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-07-07

No results posted yet for this study

Summary

Primary Endpoint

* To assess the prevalence and diagnostic performance of pre-determined echographic features in predicting the diagnosis of TBE from MPE.
* To determine the clinical, pleural fluid and echographic parameters that were different among TBE and MPE and to establish a clinical prediction model for TBE.

Secondary Endpoint

* To assess the correlation between pleural fluid parameters with ultrasound and medical thoracoscopic finding.
* To assess the optimal Pf ADA cut-off value to differentiate TBE from MPE in our region.

Conditions

  • Pleural Effusion
  • Tuberculosis, Pleural
  • Malignant Pleural Effusion

Sponsors & Collaborators

  • Hospital Queen Elizabeth, Kota Kinabalu, Sabah

    collaborator UNKNOWN

  • Institute of Respiratory Medicine Malaysia, Kuala Lumpur

    collaborator UNKNOWN

  • Hospital Serdang, Selangor

    collaborator UNKNOWN

  • University of Malaya

    collaborator OTHER

  • Hospital Melaka, Melaka

    collaborator UNKNOWN

  • Sarawak General Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05935696 on ClinicalTrials.gov